speb/financial-data huggingface dataset:
NCLIND.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 1617733000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 52754000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 52754000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Net Income: 29800000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 29800000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 29800000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 29800000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 29800000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 29800000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -52754000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -52754000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 243713000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 29800000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Operating Income: 55134000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 3413950000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 50795000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 1239403000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 53176000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 1796217000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 137783000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 23376000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.30
NCLIND.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 3358816000.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
NCLIND.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00
NCLIND.NS income_statement (annual, 2025-03-31) — +Operating Expense: 6038481000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 1688234000.00
NCLIND.NS income_statement (annual, 2025-03-31) — +Total Revenue: 13621018000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 3752512000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 1514534000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1514534000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 1357853000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 1357853000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -3755035000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -3755035000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 2122284000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 2122284000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -105842000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -105842000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 631104000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 631104000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 45647101.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 46848649.00
NCLIND.NS income_statement (annual, 2025-03-31) — Basic EPS: 5.52
NCLIND.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 1.48
NCLIND.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 446424000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 2287300000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 2287300000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -1178334000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 35993000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 35993000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 452328000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 452328000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 148916000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 148916000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 200367000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 200367000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -158315000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 148916000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 148916000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -711092000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -18407000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Change In Other Current Liabilities: -204484000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Change In Payable: 618268000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 68100000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -224854000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Changes In Cash: -297507000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Common Stock: 452328000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 452328000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 8582422000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 8582422000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 1531456000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 1531456000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 6930612000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1973219000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Current Assets: 4613196000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 4613196000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 12791000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 12791000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Current Debt: 1021657000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 1021657000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 1034448000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1034448000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 4042955000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 4042955000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 32079000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 32079000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Depreciation: 566354000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 566354000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 540700000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 144340000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 540700000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 144340000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 45647101.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 46848649.00
NCLIND.NS income_statement (annual, 2025-03-31) — Diluted EPS: 5.52
NCLIND.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.48
NCLIND.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 251972000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 69336000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Dividends Payable: 15281000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 15281000.00
NCLIND.NS income_statement (annual, 2025-03-31) — EBIT: 762785000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — EBIT: 181290000.00
NCLIND.NS income_statement (annual, 2025-03-31) — EBITDA: 1329139000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — EBITDA: 325630000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — End Cash Position: 148916000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: -48003000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 392969000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 392969000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -316320000.00
NCLIND.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 171828000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Goodwill: 100451000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 100451000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 100451000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 100451000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 1463695000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 1463695000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 14713643000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 14713643000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Gross Profit: 6690406000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 1779293000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Interest Expense: 198583000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 45434000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 198583000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 45434000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Interest Income: 30535000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 30535000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -190076000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 7964000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Inventory: 2481054000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 2481054000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 11071129000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 11071129000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -1111518000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 631104000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 631104000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Investmentsin Joint Venturesat Cost: 42006000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Joint Venturesat Cost: 42006000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Issuance Of Debt: 939026000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 937695000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 937695000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Long Term Capital Lease Obligation: 23202000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 23202000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 1467050000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 1467050000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1490252000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 1490252000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Long Term Debt Issuance: 664633000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Long Term Debt Payments: -137406000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 42006000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 42006000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Long Term Provisions: 102953000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 102953000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 9690794000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 9690794000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Net Debt: 2339791000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 2339791000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Net Income: 251972000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Net Income: 69336000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 251972000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 69336000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 340574000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 96259000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Net Income Discontinuous Operations: -88602000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Net Income Discontinuous Operations: -26923000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 251972000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 69336000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 340574000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 96259000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 428010000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 251972000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 69336000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Net Interest Income: -198583000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -45434000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: 26061000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 308741000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 527227000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -198583000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -45434000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Net PPE: 10958608000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 10958608000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: -1145543000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Net Short Term Debt Issuance: -218486000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 8481971000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 8481971000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Liabilities: 1310314000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 1310314000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 536666000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 536666000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 1429772000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 325630000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Normalized Income: 401319766.07
NCLIND.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 96259000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 862014000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Operating Income: 651925000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Operating Income: 91059000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Operating Revenue: 13621018000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 3752512000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 45232790.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 45232790.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: 670000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 670000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 432871000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 432871000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 8130093000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 8130093000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Other Inventories: 835889000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Other Inventories: 835889000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: 193008000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 92744000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 92744000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Other Non Current Liabilities: -2000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: -2000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 211493000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 90229000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 4809928000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 1369388000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Other Payable: 88359000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 88359000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Other Properties: 266398000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Other Properties: 266398000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 117779000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 117779000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 51451000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 51451000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Other Special Charges: 66272000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Payables: 1909636000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Payables: 1909636000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 32079000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 32079000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 294326000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 294326000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Pretax Income: 564202000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 135856000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -1178334000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Raw Materials: 1163432000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Raw Materials: 1163432000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 6930612000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 1973219000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 566354000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 144340000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 24419000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 24419000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -630285000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Research And Development: 1000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 15281000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 15281000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 1489773000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 1489773000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 32791000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 3276112000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 3447940000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Share Issued: 45232790.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 45232790.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 274393000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Short Term Debt Payments: -492879000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Special Income Charges: -100633000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 8582422000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 8582422000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 8481971000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 8481971000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: -39887233.93
NCLIND.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
NCLIND.NS income_statement (annual, 2025-03-31) — Tax Provision: 223629000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 39597000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.40
NCLIND.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.29
NCLIND.NS balance_sheet (annual, 2025-03-31) — Taxes Receivable: 145866000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 145866000.00
NCLIND.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -100504000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Total Assets: 16348034000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 16348034000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 10049472000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 10049472000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Total Debt: 2524700000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 2524700000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 8582422000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 8582422000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Total Expenses: 12969093000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 3661453000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 7765612000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 7765612000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 11734840000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 11734840000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3722657000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 3722657000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 31761000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 291462000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 291462000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Total Unusual Items: -100633000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
NCLIND.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: -100633000.00
NCLIND.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Tradeand Other Payables Non Current: 142363000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Tradeand Other Payables Non Current: 142363000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Work In Process: 88764000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Work In Process: 88764000.00
NCLIND.NS balance_sheet (annual, 2025-03-31) — Working Capital: 570241000.00
NCLIND.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 570241000.00
NCLIND.NS income_statement (annual, 2025-03-31) — Write Off: 35547000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 1538509000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 3384670000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 45256027.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 4.48
NCLIND.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 1473931000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 134597000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 134597000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 45256027.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 4.48
NCLIND.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 202747000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — EBIT: 415894000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — EBITDA: 550491000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 1910739000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 54916000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 54916000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Net Income: 202747000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 202747000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 202747000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 202747000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 202747000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 202747000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -54916000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -54916000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 550491000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 202747000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Operating Income: 372230000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 3384670000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 43663000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 1218325000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 360978000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 1473931000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 134597000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Special Income Charges: 0.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 158231000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.30
NCLIND.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 3012440000.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items: 0.00
NCLIND.NS income_statement (quarterly, 2025-06-30) — Total Unusual Items Excluding Goodwill: 0.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 1560652000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 3450475000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 626078000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1396619000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 589371000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Basic Average Shares: 45631881.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Basic EPS: 4.36
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 32686000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 452328000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 16206000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 176180000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 452328000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 8893658000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 2198956000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 1532624000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 3978794000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 12663000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 994394000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 1007057000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 3829058000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Current Provisions: 39112000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Depreciation And Amortization In Income Statement: 134432000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Depreciation Income Statement: 134432000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 45631881.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Diluted EPS: 4.36
NCLIND.NS income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 198955000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — EBIT: 336049000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — EBITDA: 470481000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 100451000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 100451000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 11618364000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Gross Profit: 1917851000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Interest Expense: 44730000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 44730000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Inventory: 1806924000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 11448139000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 589371000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 20023000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 1560087000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 1580110000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Long Term Provisions: 124318000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 2538275000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Net Income: 198955000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 198955000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 198955000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 198955000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 198955000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 198955000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Net Interest Income: -44730000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -44730000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 11618364000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 8793207000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 1320127000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 568202000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Normalized Income: 265693117.17
NCLIND.NS income_statement (quarterly, 2025-09-30) — Operating Income: 357199000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Operating Revenue: 3450475000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 45232790.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 410571000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Other Current Liabilities: 519515000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 8441330000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 47120000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 76570000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Other Operating Expenses: 1244418000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Other Properties: 9419408000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 188500000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 159974000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Other Special Charges: 97721000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Otherunder Preferred Stock Dividend: 0.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Payables: 997393000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Pretax Income: 291319000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 1532624000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 134432000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 45232790.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Special Income Charges: -97721000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 8893658000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 8793207000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: -30982882.83
NCLIND.NS income_statement (quarterly, 2025-09-30) — Tax Provision: 92364000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.32
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 16334101000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 10453745000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 2587167000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 8893658000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Total Expenses: 3093276000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 7440443000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 12355306000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 3611385000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 371315000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items: -97721000.00
NCLIND.NS income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: -97721000.00
NCLIND.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 149736000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 1555455000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 3429891000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 45202048.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 2.93
NCLIND.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1664883000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 151965000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 151965000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 45202048.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 2.93
NCLIND.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 132442000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — EBIT: 285982000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — EBITDA: 437947000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 1765008000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 52488000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 52488000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Net Income: 132442000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 132442000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 132442000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 132442000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 132442000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 132442000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -52488000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -52488000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 437947000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 132442000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Operating Income: 209553000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 3429891000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 76427000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 1214643000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 233494000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1664883000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 151965000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 101051000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.30
NCLIND.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 3220338000.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
NCLIND.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
NCLIND.NS income_statement (annual, 2026-03-31) — +Operating Expense: 6171406000.00
NCLIND.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 1572484000.00
NCLIND.NS income_statement (annual, 2026-03-31) — +Total Revenue: 14220844000.00
NCLIND.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 3996325000.00
NCLIND.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 628703000.00
NCLIND.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 628703000.00
NCLIND.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 1183342000.00
NCLIND.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1183342000.00
NCLIND.NS balance_sheet (annual, 2026-03-31) — Assets Held For Sale Current: 317864000.00
NCLIND.NS balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 317864000.00
NCLIND.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 658559000.00
NCLIND.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 658559000.00
NCLIND.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 42791131.00
NCLIND.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 9.81
NCLIND.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 148916000.00
NCLIND.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -1098118000.00
NCLIND.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 29130000.00
NCLIND.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 29130000.00
NCLIND.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 452328000.00
NCLIND.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 452328000.00
NCLIND.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 33101000.00
NCLIND.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 33101000.00
NCLIND.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 102342000.00
NCLIND.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 102342000.00
NCLIND.NS cash_flow (annual, 2026-03-31) — Cash Dividends Paid: -158315000.00
NCLIND.NS cash_flow (annual, 2026-03-31) — Change In Inventory: 850800000.00
NCLIND.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -181816000.00
NCLIND.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: -96376000.00
NCLIND.NS cash_flow (annual, 2026-03-31) — Change In Payable: -885830000.00
NCLIND.NS cash_flow (annual, 2026-03-31) — Change In Receivables: 174511000.00
NCLIND.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -131907000.00
NCLIND.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -115814000.00
NCLIND.NS balance_sheet (annual, 2026-03-31) — Common Stock: 452328000.00
NCLIND.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 452328000.00
NCLIND.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 9402021000.00
NCLIND.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 9402021000.00
NCLIND.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 22861000.00
NCLIND.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 22861000.00
NCLIND.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 6704418000.00
NCLIND.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 2067168000.00
NCLIND.NS balance_sheet (annual, 2026-03-31) — Current Assets: 3690278000.00
NCLIND.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 3690278000.00
NCLIND.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 7081000.00
NCLIND.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 7081000.00
NCLIND.NS balance_sheet (annual, 2026-03-31) — Current Debt: 872396000.00
NCLIND.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 872396000.00
NCLIND.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 879477000.00
NCLIND.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 879477000.00
NCLIND.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 2992222000.00
NCLIND.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 2992222000.00
NCLIND.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 33458000.00
NCLIND.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 33458000.00
NCLIND.NS cash_flow (annual, 2026-03-31) — Depreciation: 581349000.00
NCLIND.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 581349000.00
NCLIND.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 554945000.00
NCLIND.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 153749000.00
NCLIND.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 554945000.00
NCLIND.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 153749000.00
NCLIND.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 42791131.00
NCLIND.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 9.81
NCLIND.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 953915000.00
NCLIND.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 419781000.00
NCLIND.NS income_statement (annual, 2026-03-31) — EBIT: 1563007000.00
NCLIND.NS income_statement (quarterly, 2026-03-31) — EBIT: 475791000.00
NCLIND.NS income_statement (annual, 2026-03-31) — EBITDA: 2144356000.00
NCLIND.NS income_statement (quarterly, 2026-03-31) — EBITDA: 629540000.00
NCLIND.NS cash_flow (annual, 2026-03-31) — End Cash Position: 33101000.00
NCLIND.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -488896000.00
NCLIND.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 351608000.00
NCLIND.NS balance_sheet (annual, 2026-03-31) — Goodwill: 100451000.00
NCLIND.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 100451000.00
NCLIND.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 100451000.00
NCLIND.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 100451000.00
NCLIND.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 11137138000.00
NCLIND.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 11137138000.00
NCLIND.NS income_statement (annual, 2026-03-31) — Gross Profit: 7516426000.00
NCLIND.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 1929157000.00
NCLIND.NS income_statement (annual, 2026-03-31) — Interest Expense: 190361000.00
NCLIND.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 45733000.00
NCLIND.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 190361000.00